3
9
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69486 |
BMD4503-2
|
||
BMD4503-2 is an LRP5/6-sclerostin interaction inhibitor. BMD4503-2 recovers the downregulated activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. | |||
T81173 |
Setrusumab
BPS 804 |
||
Setrusumab (BPS 804)是一种针对sclerostin的全人源单克隆抗体,具有提升骨骼强度的效能,常用于研究成骨不全症(OI)及癌症治疗。 | |||
T78278 |
Blosozumab
|
||
Blosozumab (LY2541546)为针对人sclerostin (SOST)的单克隆抗体。它能促进骨生成,同时抑制骨吸收,可应用于骨质疏松症相关研究。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01633 |
SOST Protein, Rat, Recombinant (His)
sclerostin |
Rat | HEK293 Cells |
SOST Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23 kDa and the accession number is A6HJF6. | |||
TMPY-00925 |
SOST Protein, Human, Recombinant (His)
VBCH,sclerostin,DAND6,CDD,SOST1 |
Human | HEK293 Cells |
SOST Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.5 kDa and the accession number is Q9BQB4-1. | |||
TMPJ-01294 |
SOST Protein, Mouse, Recombinant (His)
Sost,Sclerostin |
Mouse | HEK293 Cells |
Sclerostin (SOST) is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. Cerberus/DAN family members are putative BMP antagonists, and include Dan, Cerberus, Gremlin, PRDC, and Caronte. While the overall sequence identity between members of the family is low, they have conserved spacing of six cysteine residues. Cerberus and Dan have an additional cysteine residue used for dimerization; however, SOST does not and is secreted as a monomer... | |||
TMPY-05113 |
SOST Protein, Human, Recombinant (His), Biotinylated
VBCH,SOST1,DAND6,sclerostin,CDD |
Human | HEK293 Cells |
SOST Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.5 kDa and the accession number is Q9BQB4-1. | |||
TMPK-01293 |
SOST Protein, Cynomolgus, Recombinant (His)
VBCH,SOST1,sclerostin,DAND6,SOST,CDD,VBCHsclerosteo... |
Cynomolgus | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. SOST Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 22.58 kDa and the accession number is XP_005584428.2. | |||
TMPK-00103 |
SOST Protein, Human, Recombinant (His & Avi), Biotinylated
VBCH,DAND6,VBCHsclerosteosis,sclerostin,SOST1,CDD,S... |
Human | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. SOST Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with N-His-Avi tag. The predicted molecular weight is 24.2 kDa and the accession number is Q9BQB4-1. | |||
TMPK-00102 |
SOST Protein, Human, Recombinant (His & Avi)
VBCHsclerosteosis,SOST1,sclerostin,SOST,CDD,DAND6,V... |
Human | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. SOST Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with N-His-Avi tag. The predicted molecular weight is 24.2 kDa and the accession number is Q9BQB4-1. | |||
TMPK-00740 |
LRP-5 Protein, Human, Recombinant (mFc)
LRP7,EVR1,LR3VBCH2,HBM,LRP5,EVR4,VBCH2,OPS,BMND1OPTA1,LR3,OP... |
Human | HEK293 Cells |
A role for low-density lipoprotein-related receptor 5 (LRP5) in human bone was first established by the identification of genetic alterations that led to dramatic changes in bone mass. Shortly thereafter, mutations that altered the function of the sclerostin (SOST) gene were also associated with altered human bone mass. Subsequent studies of LRP5 and sclerostin have provided important insights into the mechanisms by which these proteins regulate skeletal homeostasis. LRP-5 Protein, Human, Recomb... | |||
TMPK-00739 |
LRP-5 Protein, Human, Recombinant (hFc)
EVR1,BMND1,BMND1OPTA1,LRP5,LRP7,OPPG,EVR4,OPTA1,OPS,HBM,VBCH... |
Human | HEK293 Cells |
A role for low-density lipoprotein-related receptor 5 (LRP5) in human bone was first established by the identification of genetic alterations that led to dramatic changes in bone mass. Shortly thereafter, mutations that altered the function of the sclerostin (SOST) gene were also associated with altered human bone mass. Subsequent studies of LRP5 and sclerostin have provided important insights into the mechanisms by which these proteins regulate skeletal homeostasis. LRP-5 Protein, Human, Recomb... |